Haemophilia B News and Research

RSS
New project develops more efficient treatment approaches for cardiovascular diseases

New project develops more efficient treatment approaches for cardiovascular diseases

Researchers uncover genes that play a key role in the inactivation of X chromosomes

Researchers uncover genes that play a key role in the inactivation of X chromosomes

ABPI associated with NHS for 70 years in pharmaceutical research

ABPI associated with NHS for 70 years in pharmaceutical research

New, more easily administered therapies offer benefits for bleeding and clotting disorders

New, more easily administered therapies offer benefits for bleeding and clotting disorders

Gene editing within a living person for the first time

Gene editing within a living person for the first time

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Octapharma uses G:BOX Chemi XX6 imager to accurately characterise large therapeutic proteins

Octapharma uses G:BOX Chemi XX6 imager to accurately characterise large therapeutic proteins

Non-adherence to treatment increases risk of major bleeds in young people with haemophilia, study finds

Non-adherence to treatment increases risk of major bleeds in young people with haemophilia, study finds

Elite Team GB cyclist launches 'Little Bleeders' to tackle inactivity in young haemophilia patients

Elite Team GB cyclist launches 'Little Bleeders' to tackle inactivity in young haemophilia patients

New European study emphasizes need to enhance standard of haemophilia care in real life

New European study emphasizes need to enhance standard of haemophilia care in real life

An Introduction to Specialty Pharmaceuticals

An Introduction to Specialty Pharmaceuticals

Coagadex now available for rare bleeding disorder patients in the UK

Coagadex now available for rare bleeding disorder patients in the UK

European Medicines Agency approves first-ever treatment for hereditary factor X deficiency

European Medicines Agency approves first-ever treatment for hereditary factor X deficiency

New €5.6 million project aims to develop cell-based haemophilia A therapy

New €5.6 million project aims to develop cell-based haemophilia A therapy

Improved gene therapy treatment shows promise in mice with cystic fibrosis

Improved gene therapy treatment shows promise in mice with cystic fibrosis

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Approval to start trial of Videregen's replacement trachea technology

Approval to start trial of Videregen's replacement trachea technology

New report on different treatment strategies for haemophilia published

New report on different treatment strategies for haemophilia published

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019